CNE100001070
CNE100001070
QIANHONG BIO-PHARMA
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 8.34B EUR | 7.95B EUR | 9.78B EUR |
Enterprise Value | 7.02B EUR | 7.63B EUR | 9.1B EUR |
Valuation Multiples | |||
Trailing P/E | 27.17x | 29.94x | 27.26x |
Forward P/E | 21.73x | -- | -- |
Price to Sales | 5.68x | 5.21x | 6.2x |
Price to Book | 3x | 2.9x | 3.43x |
EV/Revenue | 4.78x | 5x | 5.78x |
EV/EBITDA | 21.42x | 27.19x | 25.47x |
Price to FCF (P/FCF) | 38.68x | 57.17x | 53.65x |
EV/FCF | 32.53x | 54.85x | 49.94x |
FCF Yield | 2.59% | 1.75% | 1.86% |